IGSF11 Inhibitors
The IGSF11 Inhibitors belong to a distinct chemical class characterized by their specific targeting of Immunoglobulin Superfamily Member 11 (IGSF11), a cell surface protein that plays a crucial role in various cellular processes. IGSF11, also known as SynCAM 1 (Synaptic Cell Adhesion Molecule 1), is a member of the immunoglobulin superfamily involved in cell adhesion and synaptic organization. The inhibitors designed for IGSF11 selectively modulate its activity, altering the molecular interactions and signaling cascades associated with this protein.
IGSF11 Inhibitors are meticulously designed to interact with key binding sites on the IGSF11 protein, thereby disrupting its normal function. These inhibitors typically possess a high degree of specificity, ensuring that their impact is confined to IGSF11-related cellular pathways without interfering with other essential biological processes. The development of IGSF11 Inhibitors represents a significant advancement in the field of molecular pharmacology, as it opens avenues for understanding the intricate mechanisms underlying cell adhesion, synaptic transmission, and related physiological phenomena. Researchers are exploring the potential of these inhibitors to unravel the complexities of cellular communication and pave the way for novel insights into the fundamental biology of cell interactions. Further studies on the chemical properties, mode of action, and downstream effects of IGSF11 Inhibitors are ongoing, with the aim of broadening our understanding of the functional intricacies associated with IGSF11 and its role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A known kinase inhibitor that can affect cell adhesion and communication, possibly affecting IGSF11-related signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that acts as a tyrosine kinase inhibitor, potentially altering signaling pathways that IGSF11 may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can disrupt downstream signaling pathways, potentially impacting IGSF11's role in cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that can interfere with the MAPK/ERK pathway, possibly influencing IGSF11's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that could modify cell signaling processes, possibly affecting those involving IGSF11. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can perturb cellular signaling, potentially impacting IGSF11's role. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor, which may affect cellular adhesion pathways involving IGSF11. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad-spectrum tyrosine kinase inhibitor that could affect cell communication pathways involving IGSF11. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A potent and selective Gs alpha subunit inhibitor, which may affect G-protein coupled receptor signaling involving IGSF11. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
A calcium chelator that can alter calcium-dependent signaling pathways, potentially affecting IGSF11's role. | ||||||